Disease management
The company currently has 11 locations delivering virtual-supported care, but now plans to open "several" more in the first half of 2021.
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
Along with the support of a Google Cloud-backed data platform, the partners will work to build and validate digital health programs for early intervention and engagement.